Get the Stockscreener App
0.8598
4.47%
-0.0402
Mira Pharmaceuticals Inc stock is currently priced at $0.8598, with a 24-hour trading volume of 12,549.
It has seen a -4.47% decreased in the last 24 hours and a -25.23% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $0.89 pivot point. If it approaches the $0.85 support level, significant changes may occur.
Previous Close:
$0.90
Open:
$0.9171
24h Volume:
12,549
Market Cap:
$12.71M
Revenue:
-
Net Income/Loss:
$-7.54M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
$-4.47M
1W Performance:
+3.39%
1M Performance:
-25.23%
6M Performance:
-63.41%
1Y Performance:
+0.00%
1D Range:
$0.85
$0.9171
52W Range:
$0.76
$6.48
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
Name
Mira Pharmaceuticals Inc
Sector
Industry
Phone
737-289-0835
Address
855 North Wolfe Street, Suite 601, Baltimore
Mira Pharmaceuticals Inc Stock (MIRA) Latest News
Why MariaDB Shares Are Trading Higher By Around 100%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
Why Porch Group Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Mira Pharmaceuticals Inc Stock (MIRA) Financials Data
Mira Pharmaceuticals Inc (MIRA) Net Income 2024
MIRA net income (TTM) was -$7.54 million for the quarter ending September 30, 2023.
Mira Pharmaceuticals Inc (MIRA) Cash Flow 2024
MIRA recorded a free cash flow (TTM) of -$4.47 million for the quarter ending September 30, 2023.
Mira Pharmaceuticals Inc (MIRA) Earnings per Share 2024
MIRA earnings per share (TTM) was -$0.5283 for the quarter ending September 30, 2023.
About Mira Pharmaceuticals Inc
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
0.49%
0.47%
Cap:
|
Volume (24h):